drugset

drugset / Trial / NCT00002188

A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

NCT00002188 ↗

Phase 2 Completed 27 enrolled Anderson Clinical Research Ligand Pharmaceuticals · collab

Treatment

Summary

The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	alitretinoin	Other / unclassified	—	Oral

Indications